Clovis Oncology Inc. (CLVS) declined -5.11% or -2.7 to $50.12. It is near to 1.13 million shares traded, which is 84.82% compare to the average total volume 1.33 million. The market cap of CLVS is $2.52 billion. The year to date change is -20.03%. The 52 week price range is from $45.42 to $99.45. Price of CLVS have changed -10.85% during last week. It have changed -20.56% over last month, -27.02% over last 3 months, -31.66% over last 6 months and -13.47% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 61.61. It is 22.92% above current price. The 200-day Moving Averages for CLVS is 69.63. It is 38.93% above current price. The 52-week High is 99.45. It is 98.42% from the current price. The 52-week Low is 45.42. It is -9.38% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLVS is 6.36 on 2018-01-12. Short % to float is 14.82%. There are some statistics of CLVS. It is has market cap $2.52 billion. The share outstanding is 50.35 million. The average volume is 1.33 million. The revenue is 38.55M. The gross profit is 30.44M. The percent of top 15 Institution holding is 95.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -203.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -59.79%.